A new study of leukemia drug Mylotarg, pulled from the U.S. market last year due to safety concerns, found it to be effective when used at low doses in older adults but questions about toxicity remain.
Popular Posts:
- Man dies feet from ER after hospital says to call 911
- HOME IMPROVEMENT WALTIP.COM: A letter from Mom and Dad
- HOME IMPROVEMENT WALTIP.COM: GOP Raking In $ From Health Insurance …
- Roche says skin cancer drug substantially shrinks
- Roche says skin cancer drug substantially shrinks